Sentral Clinical Research Service is categorized under Services (Unclassified) in Cincinnati, OH and active since 2010.
Sentral Clinical Research Service was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Williams Dirkes, President at the company’s single location by writing to 8041 Hosbrook Road # 200, Cincinnati, Ohio OH 45236 or by phoning (513) 488-1295. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Sentral Clinical Research Service |
Contact Person: | Williams Dirkes, President |
Address: | 8041 Hosbrook Road # 200, Cincinnati, Ohio 45236 |
Phone Number: | (513) 488-1295 |
Annual Revenue (USD): | Unknown |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Services (Unclassified) |
SIC Code: | 8999 |
NAICS Code: | 5419100 |
Share This Business: |
Sentral Clinical Research Service was started in 2010 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Williams Dirkes, President for inquiries that concern Sentral Clinical Research Service by calling the company number (513) 488-1295, as your correspondence is most welcome. Additionally, the physical location of the single location of Sentral Clinical Research Service can be found at the coordinates 39.20406,-84.37135 as well as the street address 8041 Hosbrook Road # 200 in Cincinnati, Ohio 45236.
For its online presence, you may visit Sentral Clinical Research Service’s website at and engage with its social media outlets through on Twitter and on Facebook.